African nations chart path toward pharmaceutical independence amid resource constraints

Africans demand control of their own health future as funding crisis deepens Between 70 and 100 percent of pharmaceutical products used across Africa are imported. Approximately 99 percent of vaccines come from abroad. For communities depending on these systems during outbreaks or health emergencies, that reliance is not theoretical. It determines which medicines reach a clinic, how quickly a vaccine arrives, and whether a health system can function under pressure. These figures formed the factual foundation of the African Union Extraordinary Summit on Health, held in Accra in recent weeks. The gathering brought together heads of state, policymakers, health leaders, development partners and global health experts around a single stated purpose: building health systems shaped by African leadership, investment and innovation rather than external dependence. The summit's timing coincided with a visit from Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization. Speaking to WHO Ghana Country Office staff, Ghebreyesus offered a statement that distilled the week's central tension: "A lack of funding will not break this Organization, but a lack of integrity will." The remark signaled WHO's institutional alignment with the summit's core argument, that health security on the continent requires more than emergency response protocols. It demands sustained, locally-rooted investment in pharmaceutical manufacturing, health workforce development and innovation infrastructure. Ghebreyesus's presence in Ghana carried symbolic weight. His meetings with President John Dramani Mahama focused on strengthening health systems, advancing universal health coverage and positioning health as central to national and continental development agendas. He also engaged with the United Nations Country Team in Ghana, emphasizing cross-sectoral collaboration on health challenges that do not fit neatly within single institutional mandates. The summit reflected a broader reframing of health within African policy discourse. Rather than treating it as a discrete social good, participants positioned health as foundational to economic growth, social stability and long-term development. Strong health systems protect communities, support productive populations and strengthen countries' capacity to withstand future shocks. This reorientation moves health from the periphery of budget discussions into the center of economic strategy, with direct consequences for how governments allocate resources and prioritize spending. Ghana's role as host underscored the country's established position as a leader in advancing health development across the continent. The choice also created space for dialogue on how Africa might transition from structural dependence to genuine ownership of health solutions. The summit covered multiple interconnected fronts: strengthening primary health care infrastructure, achieving universal health coverage, improving pandemic preparedness and expanding access to essential health products. Each priority emerged from what participants described as an honest assessment of the continent's position. Despite significant progress in recent years, structural vulnerabilities persist. A health system that relies on imported vaccines and pharmaceuticals cannot control its own response timeline during an outbreak. A workforce trained primarily outside the continent may not remain to serve local populations. Manufacturing capacity concentrated elsewhere means that production decisions reflect external commercial interests rather than African health needs. By contrast, Ghebreyesus's remarks to WHO staff in Accra addressed the institutional dimension of this challenge directly. He instructed staff to "stand with science, facts and evidence" rather than competing interests and opinions, grounding institutional purpose in something that cannot be budget-cut away. The instruction carried implicit acknowledgment that funding pressures are real and that institutional integrity requires clarity about what guides decision-making when resources are constrained. The summit's discussions revealed consensus on the problem. African leaders and health experts articulated a shared understanding that the continent's current dependency structure creates fragility. The harder question, left open as the summit concluded in Accra, concerns whether the investment commitments, manufacturing capacity and political will necessary to build genuine health sovereignty can be sustained long enough to translate into lived reality for the communities these systems are designed to serve. No timeline for that transition was announced, and no new funding mechanisms were formally established during the gathering.